$120.00 Original price was: $120.00.$90.00Current price is: $90.00.
One vial 10 mg is now $90 for a limited time.
Compound: SS-31 (Elamipretide / MTP-131)
Concentration: 10mg per vial
Format: Lyophilized Powder
Chemical Classification: Synthetic Mitochondria-Targeting Tetrapeptide / Szeto-Schiller Peptide
Chemical Profile: SS-31 is a synthetic aromatic-cationic tetrapeptide belonging to the Szeto-Schiller peptide family. Structurally, it consists of D-arginine, 2,6-dimethyltyrosine (Dmt), lysine, and C-terminal amidated phenylalanine. SS-31 has been extensively investigated in controlled laboratory systems for its selective interaction with cardiolipin, a phospholipid concentrated within the inner mitochondrial membrane. Experimental studies indicate that this interaction can modify cardiolipin-cytochrome c behavior, mitochondrial electron-transfer kinetics, membrane-associated oxidative processes, and bioenergetic signaling. These characteristics make SS-31 a defined molecular probe for studying mitochondrial membrane chemistry and cardiolipin-dependent processes.
Monthly subscription three vials of 10mg for a total of 30mg was $270 now $200
Important Legal & Safety Notice: This Genoscience product is intended exclusively for in-vitro research and analytical use. It is not intended for human or animal consumption or administration. Researchers are solely responsible for ensuring that handling, reconstitution, storage, and experimental protocols comply with all applicable institutional, ethical, and legal requirements.
$60.00 Original price was: $60.00.$40.00Current price is: $40.00.
$60.00 Original price was: $60.00.$40.00Current price is: $40.00.
$50.00 Original price was: $50.00.$30.00Current price is: $30.00.
$70.00 – $130.00Price range: $70.00 through $130.00
$60.00 Original price was: $60.00.$35.00Current price is: $35.00.
You must be at least 21 years old to enter Genoscience and review products intended for laboratory research use only.
Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.